English
简体中文
Total: £ 56.28
Published Date: 2026-03-25 | Pages: 112 | Tables: 110 | Pharma & Healthcare
The global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Non-carrier Added Lutetium-177 (n.c.a. Lu-177) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lutetium-177 is a radioactive isotope of lutetium, a rare earth metal, with a half-life of about 6.7 days. Lutetium-177 is a beta emitter, meaning that as it decays it releases beta radiation—high-energy electrons the unstable atom can no longer contain. Beta radiation is particularly useful for cancer treatment because of how effectively attenuated it is by biological soft tissues. By applying radioisotopes like Lu-177 to the right area, the beta radiation released can destroy tumors while causing minimal damage to the surrounding healthy tissue. Lu-177 also emits gamma radiation.
Lutetium-177 can be produced as carrier added (ca) and no carrier added (nca) from enriched 177Lu or 176Yb. The later requires separation of Lu from the Yb target following irradiation. Non-carrier added Lutetium-177 (n.c.a. Lu-177) is emerging as a radioisotope of choice for targeted radionuclide therapy.
The North American market for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) include SHINE Technologies, NRG, Eckert & Ziegler, ITM, Isotopia Ltd, ANSTO, Monrol, China Tongfu Stock, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Non-carrier Added Lutetium-177 (n.c.a. Lu-177). The Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market size, estimates, and forecasts are provided in terms of sales volume (Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market comprehensively. Regional market sizes by Specification, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Non-carrier Added Lutetium-177 (n.c.a. Lu-177) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Specification, by Application, and by region.
Market Segmentation
By Company
SHINE Technologies
NRG
Eckert & Ziegler
ITM
Isotopia Ltd
ANSTO
Monrol
China Tongfu Stock
Segment by Specification
50 GBq/mL
200 GBq/mL
Others
by Application
Targeted Molecular Radiotherapy
Medical Imaging
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Specification, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Non-carrier Added Lutetium-177 (n.c.a. Lu-177) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Specification, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Overview
1.1 Product Definition
1.2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Specification
1.2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Specification: 2025 vs 2032
1.2.2 50 GBq/mL
1.2.3 200 GBq/mL
1.2.4 Others
1.3 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Application
1.3.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Application: 2025 vs 2032
1.3.2 Targeted Molecular Radiotherapy
1.3.3 Medical Imaging
1.4 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size Estimates and Forecasts
1.4.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue 2021–2032
1.4.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales 2021–2032
1.4.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Competition by Manufacturers
2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Product Types and Applications
2.7 Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Date of Entry into the Industry
2.8 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Competitive Situation and Trends
2.8.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Players Market Share by Revenue
2.8.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Scenario by Region
3.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region: 2021–2032
3.2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region: 2021–2026
3.2.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region: 2027–2032
3.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region: 2021–2032
3.3.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region: 2021–2026
3.3.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region: 2027–2032
3.4 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Facts & Figures by Country
3.4.1 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (2021–2032)
3.4.3 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Facts & Figures by Country
3.5.1 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (2021–2032)
3.5.3 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Facts & Figures by Region
3.6.1 Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (2021–2032)
3.6.3 Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Facts & Figures by Country
3.7.1 Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (2021–2032)
3.7.3 Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Specification (2021–2032)
4.1.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Specification (2021–2026)
4.1.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Specification (2027–2032)
4.1.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Specification (2021–2032)
4.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Specification (2021–2032)
4.2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Specification (2021–2026)
4.2.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Specification (2027–2032)
4.2.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Specification (2021–2032)
4.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price by Specification (2021–2032)
5 Segment by Application
5.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application (2021–2032)
5.1.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application (2021–2026)
5.1.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application (2027–2032)
5.1.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Application (2021–2032)
5.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application (2021–2032)
5.2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application (2021–2026)
5.2.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application (2027–2032)
5.2.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Application (2021–2032)
5.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 SHINE Technologies
6.1.1 SHINE Technologies Company Information
6.1.2 SHINE Technologies Description and Business Overview
6.1.3 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.1.5 SHINE Technologies Recent Developments/Updates
6.2 NRG
6.2.1 NRG Company Information
6.2.2 NRG Description and Business Overview
6.2.3 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.2.5 NRG Recent Developments/Updates
6.3 Eckert & Ziegler
6.3.1 Eckert & Ziegler Company Information
6.3.2 Eckert & Ziegler Description and Business Overview
6.3.3 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.3.5 Eckert & Ziegler Recent Developments/Updates
6.4 ITM
6.4.1 ITM Company Information
6.4.2 ITM Description and Business Overview
6.4.3 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.4.5 ITM Recent Developments/Updates
6.5 Isotopia Ltd
6.5.1 Isotopia Ltd Company Information
6.5.2 Isotopia Ltd Description and Business Overview
6.5.3 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.5.5 Isotopia Ltd Recent Developments/Updates
6.6 ANSTO
6.6.1 ANSTO Company Information
6.6.2 ANSTO Description and Business Overview
6.6.3 ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.6.5 ANSTO Recent Developments/Updates
6.7 Monrol
6.7.1 Monrol Company Information
6.7.2 Monrol Description and Business Overview
6.7.3 Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.7.5 Monrol Recent Developments/Updates
6.8 China Tongfu Stock
6.8.1 China Tongfu Stock Company Information
6.8.2 China Tongfu Stock Description and Business Overview
6.8.3 China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Portfolio
6.8.5 China Tongfu Stock Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Industry Chain Analysis
7.2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Production Mode & Process Analysis
7.4 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Marketing
7.4.1 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Channels
7.4.2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Distributors
7.5 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Customer Analysis
8 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Dynamics
8.1 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Industry Trends
8.2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Drivers
8.3 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Challenges
8.4 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Specification (US$ Million), 2025 vs 2032
Table 2. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) of Key Manufacturers (2021–2026)
Table 5. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Product Types and Applications
Table 12. Global Key Manufacturers of Non-carrier Added Lutetium-177 (n.c.a. Lu-177), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (Dose), 2021–2026
Table 18. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Region (2021–2026)
Table 19. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (Dose), 2027–2032
Table 20. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Region (2027–2032)
Table 21. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Region (2021–2026)
Table 23. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Region (2027–2032)
Table 25. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2021–2026
Table 27. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2027–2032
Table 28. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2021–2026
Table 32. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2027–2032
Table 33. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (Dose), 2021–2026
Table 37. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (Dose), 2027–2032
Table 38. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2021–2026
Table 42. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2027–2032
Table 43. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2021–2026
Table 47. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Country (Dose), 2027–2032
Table 48. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Specification (2021–2026)
Table 51. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Specification (2027–2032)
Table 52. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Specification (2021–2026)
Table 53. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Specification (2027–2032)
Table 54. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (US$ Million) by Specification (2021–2026)
Table 55. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (US$ Million) by Specification (2027–2032)
Table 56. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Specification (2021–2026)
Table 57. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Specification (2027–2032)
Table 58. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Specification (2021–2026)
Table 59. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Specification (2027–2032)
Table 60. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Application (2021–2026)
Table 61. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Application (2027–2032)
Table 62. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Application (2021–2026)
Table 63. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Application (2027–2032)
Table 64. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Application (2021–2026)
Table 67. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Application (2027–2032)
Table 68. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Application (2021–2026)
Table 69. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Application (2027–2032)
Table 70. SHINE Technologies Company Information
Table 71. SHINE Technologies Description and Business Overview
Table 72. SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 74. SHINE Technologies Recent Developments/Updates
Table 75. NRG Company Information
Table 76. NRG Description and Business Overview
Table 77. NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 79. NRG Recent Developments/Updates
Table 80. Eckert & Ziegler Company Information
Table 81. Eckert & Ziegler Description and Business Overview
Table 82. Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 84. Eckert & Ziegler Recent Developments/Updates
Table 85. ITM Company Information
Table 86. ITM Description and Business Overview
Table 87. ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 89. ITM Recent Developments/Updates
Table 90. Isotopia Ltd Company Information
Table 91. Isotopia Ltd Description and Business Overview
Table 92. Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 94. Isotopia Ltd Recent Developments/Updates
Table 95. ANSTO Company Information
Table 96. ANSTO Description and Business Overview
Table 97. ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 99. ANSTO Recent Developments/Updates
Table 100. Monrol Company Information
Table 101. Monrol Description and Business Overview
Table 102. Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 104. Monrol Recent Developments/Updates
Table 105. China Tongfu Stock Company Information
Table 106. China Tongfu Stock Description and Business Overview
Table 107. China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product
Table 109. China Tongfu Stock Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Distributors List
Table 113. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Customers List
Table 114. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Trends
Table 115. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Drivers
Table 116. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Challenges
Table 117. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-carrier Added Lutetium-177 (n.c.a. Lu-177)
Figure 2. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Specification (US$ Million), 2021–2032
Figure 3. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Share by Specification: 2025 & 2032
Figure 4. 50 GBq/mL Product Picture
Figure 5. 200 GBq/mL Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Share by Application: 2025 & 2032
Figure 9. Targeted Molecular Radiotherapy
Figure 10. Medical Imaging
Figure 11. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size (US$ Million), 2021–2032
Figure 13. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose), 2021–2032
Figure 14. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Average Price (US$/Dose), 2021–2032
Figure 15. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Report Years Considered
Figure 16. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Share by Manufacturers in 2025
Figure 17. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Players: Market Share by Revenue in Non-carrier Added Lutetium-177 (n.c.a. Lu-177) in 2025
Figure 19. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Country (2021–2032)
Figure 22. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Country (2021–2032)
Figure 23. United States Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Country (2021–2032)
Figure 26. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Country (2021–2032)
Figure 27. Germany Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Region (2021–2032)
Figure 34. China Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Country (2021–2032)
Figure 42. Latin America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Specification (2021–2032)
Figure 53. Global Revenue Market Share of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Specification (2021–2032)
Figure 54. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Specification (2021–2032)
Figure 55. Global Sales Market Share of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Application (2021–2032)
Figure 56. Global Revenue Market Share of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Application (2021–2032)
Figure 57. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Price (US$/Dose) by Application (2021–2032)
Figure 58. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
